What are the 2 most common genotypes of Hep C?
Treatment regimens for Hep C are usually __ to ___ weeks
Hep C virus uses what to replicate?
Healthy cells
What drugs are these?
NS3/4A Protease Inhibitors
What drugs are these?
NS5A Inhibitors
What drugs are these?
NS5B Polymerase Inhibitors
What category?
NS5B Nucleoside Polymerase Inhibitor
Which category?
NS5B Non-Nucleoside Polymerase Inhibitors
Which category?
NS5A Inhibitors: replication complex inhibitor
NS3/4A Protease Inhibitors: inhibits ___ replication directly binding to the NS3/4A protease that cleaves HCV - encoded polyproteins
HCV
Which 2 HCV meds have been discontinued?
What 2 lab tests are recommended at any time prior to starting antiviral therapy?
What 4 lab tests are recommended within 12 weeks prior to starting antiviral therapy?
Pts w/ current or prior hx of ____ or w/ a current CTP score of 7 or greater should NOT receive tx w/ regiments that contain ____ protease inhibitors due to increased blood levels / lack of safety data
All patients initiating HCV direct acting antiviral (DAA) therapy should be assessed for ______ w/ HBsAg testing and for evidence of ____ w/ anti-HBs and anti-HBc testing
What 3 tests are recommended after 4 weeks of tx and as clinically indicated?
Patients receiving _____/_____ should be monitored with a hepatic function panel at 8 weeks and again at 12 weeks if receiving 16 weeks of tx
Elbasvir / Grazoprevir
A 10-fold increase in ____ activity at any time during tx should prompt discontinuation of therapy
alanine aminotransferase (ALT)
An increase in ALT <10-fold that is accompanied by what 7 things should also prompt discontinution of therapy?
Asymptomatic increases in ALT <10-fold should be closely monitored w/ repeat testing at ___ week intervals. If levels remain persistently elevated, consideration should be given to discontinue therapy
2
Which part of Hep C Virus Lifecycle?
Which part of the Hep C Virus Lifecycle?
RNA replication